We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top 3 Healthcare Mutual Funds to Strengthen Your Portfolio
Read MoreHide Full Article
Investors often rely on the healthcare sector to safeguard their investments. This is because healthcare services do not see their demand varying much with market conditions and thus offer sufficient protection to the capital invested.
Many pharmaceutical companies also offer regular dividends. Companies that consistently pay out dividends are financially stable and generate stable cash flows, irrespective of market conditions. Mutual funds are the perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Fidelity Select Medical Technology and Devices Portfolio fund aims for capital growth. FSMEX invests the majority of its assets in companies engaged in activities such as research, manufacturing, supply and sale of medical equipment and related technologies. FSMEX invests in common stocks and in U.S. and non-U.S. companies.
Fidelity Select Medical Technology and Devices Portfolio has three-year annualized returns of 28%. As of the end of December 2021, FSMEX held 77 issues with 14.19% of its assets invested in Thermo Fisher Scientific Inc.
Fidelity Select Biotechnology Portfolio fund seeks high capital growth. FBIOX invests most of its assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes. FBIOX invests in common stocks and in U.S. and non-U.S. companies.
Fidelity Select Biotechnology Portfolio has three-year annualized returns of 18.1%. FBIOX has an expense ratio of 0.70% compared with the category average of 1.03%.
T. Rowe Price Health Sciences Fund is a non-diversified fund that aims for capital appreciation. PRHSX invests in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences.
T. Rowe Price Health Sciences Fund has three-year annualized returns of 23.9%. Ziad Bakri has been one of the fund managers of PRHSX since 2016.
Image: Bigstock
Top 3 Healthcare Mutual Funds to Strengthen Your Portfolio
Investors often rely on the healthcare sector to safeguard their investments. This is because healthcare services do not see their demand varying much with market conditions and thus offer sufficient protection to the capital invested.
Many pharmaceutical companies also offer regular dividends. Companies that consistently pay out dividends are financially stable and generate stable cash flows, irrespective of market conditions. Mutual funds are the perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below we share with you three top-ranked healthcare mutual funds — Fidelity Select Medical Technology and Devices Portfolio (FSMEX - Free Report) , Fidelity Select Biotechnology Portfolio (FBIOX - Free Report) and T. Rowe Price Health Sciences Fund (PRHSX - Free Report) . Each has a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of healthcare mutual funds.
Fidelity Select Medical Technology and Devices Portfolio fund aims for capital growth. FSMEX invests the majority of its assets in companies engaged in activities such as research, manufacturing, supply and sale of medical equipment and related technologies. FSMEX invests in common stocks and in U.S. and non-U.S. companies.
Fidelity Select Medical Technology and Devices Portfolio has three-year annualized returns of 28%. As of the end of December 2021, FSMEX held 77 issues with 14.19% of its assets invested in Thermo Fisher Scientific Inc.
Fidelity Select Biotechnology Portfolio fund seeks high capital growth. FBIOX invests most of its assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes. FBIOX invests in common stocks and in U.S. and non-U.S. companies.
Fidelity Select Biotechnology Portfolio has three-year annualized returns of 18.1%. FBIOX has an expense ratio of 0.70% compared with the category average of 1.03%.
T. Rowe Price Health Sciences Fund is a non-diversified fund that aims for capital appreciation. PRHSX invests in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences.
T. Rowe Price Health Sciences Fund has three-year annualized returns of 23.9%. Ziad Bakri has been one of the fund managers of PRHSX since 2016.
To view the Zacks Rank and the past performance of all healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>